Identification of Prognosis-related Alternative Splicing Events in Kidney Renal Clear Cell Carcinoma
Overview
Molecular Biology
Authors
Affiliations
Alternative splicing (AS) contributes to protein diversity by modifying most gene transcriptions. Cancer generation and progression are associated with specific splicing events. However, AS signature in kidney renal clear cell carcinoma (KIRC) remains unknown. In this study, genome-wide AS profiles were generated in 537 patients with KIRC in the cancer genome atlas. With a total of 42 522 mRNA AS events in 10 600 genes acquired, 8164 AS events were significantly associated with the survival of patients with KIRC. Logistic regression analysis of the least absolute shrinkage and selection operator was conducted to identify an optimized multivariate prognostic predicting mode containing four predictors. In this model, the receptor-operator characteristic curves of the training set were built, and the areas under the curves (AUCs) at different times were >0.88, thus indicating a stable and powerful ability in distinguishing patients' outcome. Similarly, the AUCs of the test set at different times were >0.73, verifying the results of the training set. Correlation and gene ontology analyses revealed some potential functions of prognostic AS events. This study provided an optimized survival-predicting model and promising data resources for future in-depth studies on AS mechanisms in KIRC.
Genome-Wide Association Study of Reproductive Traits in Large White Pigs.
Hong Y, Tan C, He X, Wu D, Zhang Y, Song C Animals (Basel). 2024; 14(19).
PMID: 39409823 PMC: 11475698. DOI: 10.3390/ani14192874.
Zhu L, Wang Z, Sun Y, Giamas G, Stebbing J, Yu Z Front Oncol. 2022; 11:778637.
PMID: 35004299 PMC: 8728792. DOI: 10.3389/fonc.2021.778637.
Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing.
Zhang D, Zou D, Deng Y, Yang L J Ovarian Res. 2021; 14(1):120.
PMID: 34526089 PMC: 8442315. DOI: 10.1186/s13048-021-00866-1.
He M, Li C, Tang W, Kang Y, Zuo Y, Wang Y Immun Inflamm Dis. 2021; 9(4):1529-1540.
PMID: 34469062 PMC: 8589399. DOI: 10.1002/iid3.506.
He M, Hu F Int J Mol Sci. 2021; 22(16).
PMID: 34445498 PMC: 8395830. DOI: 10.3390/ijms22168789.